believe study of bimagrumab semaglutide 🔬 The Phase 2b trial just redefined what quality weight loss looks like., + works through two distinct mechanisms:, 💉 Semaglutide suppresses appetite via central GLP-1 Bimagrumab-Semaglutide Combination Achieves Significant Weight

van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG et al (2021) Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial

However, according to the release on their site this is not what HIMS is doing at all

This medication works by mimicking a naturally occurring hormone called GLP-1, which slows stomach emptying and signals fullness to the brain, creating a sustainable approach to calorie reduction without the extreme hunger often associated with traditional diets

99.5% of GI events were non-serious and 98.1% were mild-to-moderate

For patients who have resolved their diabetes using a GLP-1 for weight loss and glucose control, they may have a return of their type 2 diabetes, says Lofton, who adds that it varies from person to person

Even as techniques improved, they permanently altered anatomy